Significant response to oral etoposide in the treatment of an unresectable cardiac sarcoma

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 4, 2014, Pages

  Collins, Chelsea L ^a   Bartz, Peter J ^a   Lal, David R ^a   Segura, Annette D ^a   Woods, Ronald K ^a   Tower, Richard L ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

chemotherapy; rare tumors; soft tissue sarcomas

Indexed keywords

AMIODARONE; CARBOPLATIN; CD99 ANTIGEN; DEXAMETHASONE; ETOPOSIDE; IFOSFAMIDE;

ABDOMINAL PAIN; ABNORMAL RESPIRATORY SOUND; ANOREXIA; ARTICLE; BONE MARROW BIOPSY; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIAC SARCOMA; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY; CRYOTHERAPY; DOSE RESPONSE; DYSPNEA; FACE EDEMA; FATIGUE; FEMALE; HEART ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; NEEDLE BIOPSY; ORBIT EDEMA; POLYPLOIDY; PRIORITY JOURNAL; SARCOMA; SCHOOL CHILD; STERNOTOMY; TACHYCARDIA; TUMOR VOLUME; VASCULAR PATENCY; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOPSY; CHILD; ETOPOSIDE; FEMALE; HEART NEOPLASMS; HUMANS; REMISSION INDUCTION; SARCOMA;

EID: 84899905832     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318290c3b8     Document Type: Article

References (18)

1. Reynen K. Frequency of primary tumors of the heart. Am J Cardiol. 1996;77:107.
2. Orlandi A, Ferlosio A, Roselli M, et al. Cardiac sarcomas: an update. J Thorac Oncol. 2010;5:1483-1489.
3. Hamidi M, Moody JS, Weigel TL, et al. Primary cardiac sarcoma. Ann Thorac Surg. 2010;90:176-181.
4. Kim MP, Correa AM, Blackmon S, et al. Outcomes after rightside heart sarcoma resection. Ann Thorac Surg. 2011;91: 770-776.
5. Llombart-Cussac A, Pivot X, Contesso G, et al. Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience. Br J Cancer. 1998;78:1624-1628.
6. Putnam JB Jr, Sweeney MS, Colon R, et al. Primary cardiac sarcomas. Ann Thorac Surg. 1991;51:906-910.
7. Simpson L, Kumar SK, Okuno SH, et al. Malignant primary cardiac tumors: review of a single institution experience. Cancer. 2008;112:2440-2446.
8. Bakaeen FG, Jaroszewski DE, Rice DC, et al. Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era. J Thorac Cardiovasc Surg. 2009;137: 1454-1460.
9. Truong PT, Jones SO, Martens B, et al. Treatment and outcomes in adult patients with primary cardiac sarcoma: the British Columbia Cancer Agency experience. Ann Surg Oncol. 2009;16:3358-3365.
10. Gowdamarajan AM, Robert E. Therapy for primary cardiac tumors: is there a role for heart transplantation? Curr Opin Cardiol. 2000;15:121-125.
11. Talbot SM, Taub RN, Keohan ML, et al. Combined heart and lung transplantation for unresectable primary cardiac sarcoma. J Thorac Cardiovasc Surg. 2002;124:1145-1148.
12. Uberfuhr P, Meiser B, Fuchs A, et al. Heart transplantation: an approach to treating primary cardiac sarcoma? J Heart Lung Transplant. 2002;21:1135-1139.
13. Ahlmann ER, Falkinstein Y, Fedenko AN, et al. Cryoablation and resection influences patient survival for soft tissue sarcomas: impact on survivorship and local recurrence. Clin Orthop Relat Res. 2007;459:174-181.
14. Rathore KS, Hussenbocus S, Stuklis R, et al. Novel strategies for recurrent cardiac myxoma. Ann Thorac Surg. 2008;85:2125-2126.
15. Kebudi R, Gorgun O, Ayan I. Oral etoposide for recurrent/progressive sarcomas of childhood. Pediatr Blood Cancer. 2004;42:320-324.
16. Davidson A, Gowing R, Lowis S, et al. Phase II study of 21 day schedule oral etoposide in children. New agents group of the United Kingdom Children's Cancer Study Group (UKCCSG). Eur J Cancer. 1997;33:1816-1822.
17. Le Deley MC, Vassal G, Taibi A, et al. High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults. Pediatr Blood Cancer. 2005;45:25-31.
18. Le Deley MC, Leblanc T, Shamsaldin A, et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a casecontrol study by the Societe Francaise D'oncologie Pediatrique. J Clin Oncol. 2003;21:1074-1081.